{"nctId":"NCT00335725","briefTitle":"Efficacy and Tolerability of Human FSH Versus Recombinant FSH (Follitropin Alpha) in ICSI.","startDateStruct":{"date":"2003-03"},"conditions":["Infertility"],"count":151,"armGroups":[{"label":"Fostimon","type":"EXPERIMENTAL","interventionNames":["Drug: Follicle Stimulating Hormone"]},{"label":"Gonal-F","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Follicle Stimulating Hormone"]}],"interventions":[{"name":"Follicle Stimulating Hormone","otherNames":["highly purified human derived FSH; Fostimon"]},{"name":"Follicle Stimulating Hormone","otherNames":["rec FSH; Gonal F"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\nWomen undergoing ovarian stimulation for IntraCytoplasmic Sperm Injection (ICSI) with the following characteristics:\n\n\\>/= 18 and \\< 40 years old BMI between 19 and 30 kg/m2 less than 3 previous completed cycles basal FSH level less than 10 IU/l within the 6 months prior to the study\n\nExclusion Criteria:\n\nage \\< 18 and \\>/= 40 years primary ovarian failure or women known as poor responders, i.e. requiring more than 225 IU of FSH as starting dose in previous treatment cycles or having less than 3 oocytes retrieved or with an oestradiol serum concentration \\< 900 pmol/l (250 pg/ml) ovarian cysts \\> 20 mm oocyte donation thawed embryos replacement patients affected by pathologies associated with any contraindication of being pregnant ascertained or presumptive hypersensitivity to the active principle and/or their ingredients abnormal bleeding of undetermined origin uncontrolled thyroid or adrenal dysfunction neoplasias severe impairment of the renal and/or hepatic functions women deprived of their freedom by administrative or legal decision","healthyVolunteers":false,"sex":"FEMALE","minimumAge":"18 Years","maximumAge":"40 Years","stdAges":["ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Total Number of Oocytes Retrieved","description":"Total number of oocytes retrieved","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"10.9","spread":"4.9"},{"groupId":"OG001","value":"12.0","spread":"5.6"}]}]}]},{"type":"SECONDARY","title":"Clinical Pregnancy Rate","description":"clinical pregnancy rate defined as the presence of gestation sac and heart beat.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"30.1","spread":null},{"groupId":"OG001","value":"29.2","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":2,"n":73},"commonTop":["Ovarian cyst","spontaneous abortion","tiredness"]}}}